Thursday, February 20, 2020
News on Pathogens and Preparedness

COVID-19 | SARS-CoV-2 Coronavirus Portal

The W.H.O. announced on Feb. 11 a new name for the disease caused by the current novel coronavirus epidemic: Coronavirus Disease 2019 (COVID-19). As for the virus itself, the International Committee on Taxonomy of Viruses has decided on SARS-CoV-2, which “formally recognizes this virus as a sister to severe acute respiratory syndrome coronaviruses.” #COVID19 and #SARSCoV2 are the common social media signatures we are encouraging people use.

The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

FEATURED ARTICLES

Senators Call on Trump Administration to Immediately Fill Global Health Security Position

Senators Call on Trump Administration to Immediately Fill Global Health Security Position

U.S. Senator Brian Schatz (D-Hawai‘i) and 26 of his Senate colleagues called on National Security Advisor Robert O’Brien in a Feb. 18 letter to appoint…

Why It’s Important to Study Coronaviruses in African Bats

Why It’s Important to Study Coronaviruses in African Bats

The current outbreak of a new coronavirus disease, named COVID-19, raises the question of where diseases like this come from and where the risks lie.…

Rep. Chip Roy Letter to Trump Admin Seeks Answers on COVID-19 Risks to Joint Base San Antonio Community

Rep. Chip Roy Letter to Trump Admin Seeks Answers on COVID-19 Risks to Joint Base San Antonio Community

As a member of Congress representing large portions of San Antonio, including Joint Base San Antonio, Representative Chip Roy sent a letter on Feb. 18…

HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine

HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine

Racing to develop a vaccine against the 2019 novel coronavirus, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…

J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics

J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics

Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part…

Coronavirus Outbreak Puts ‘Open Science’ Under a Microscope

Coronavirus Outbreak Puts ‘Open Science’ Under a Microscope

As health authorities isolate the sick, set up quarantines and close borders, early efforts to stop a coronavirus pandemic are also trying something completely different:…

View All Featured News


RESOURCES | LINKS


HEADLINE NEWS

WHO Director Fights to Prevent a Pandemic Without Offending China

WHO Director Fights to Prevent a Pandemic Without Offending China

If Tedros wants WHO to stay informed about what’s happening in China and influence how the country handles the epidemic, he cannot afford to antagonize…

The U.S. Has a Biodefense Strategy. It Just Isn’t Following It.

The U.S. Has a Biodefense Strategy. It Just Isn’t Following It.

The US has a biodefense strategy—it just isn’t following it. In 2018, the Trump administration released a National Biodefense Strategy which was supposed to help…

China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19

China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19

A randomized, controlled trial is the gold standard of clinical research. But pulling one together for Covid-19 is complicated by the realities of working in…

Why Do Some of the Outbreak Genomes Have More Mutations Than Others?

Why Do Some of the Outbreak Genomes Have More Mutations Than Others?

Recent news reports have included speculation that the SARS-CoV-2 virus is ‘mutating’ and ‘evolving’ amid increasing concern that the outbreak could present an even more…

Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient

Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient

Virologist Matthew Frieman at the University of Maryland School of Medicine is just one of the scientists cleared to receive samples of the virus derived…

Masks vs. Respirators: Experts Explain COVID-19 Recommendations

Masks vs. Respirators: Experts Explain COVID-19 Recommendations

In its newly published infection prevention and control recommendations for COVID-19, the US Centers for Disease Control and Prevention (CDC) recommends the use of N95…

View All Headline News


RESEARCH HIGHLIGHTS

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

MERS Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai

Previous published serological studies showed that sera of Bactrian camels were all negative for MERS-CoV antibodies, suggesting that Bactrian camels may not be a reservoir of MERS-CoV.…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

New Technology May Significantly Reduce Diagnostic Time of Coronavirus

Based on a combination of optics and magnetic particles 100 samples of patients potentially infected with the virus can rapidly be tested and diagnosed in approximately 15…

Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses

The drug EIDD-1931 was effective against SARS and MERS viruses in the laboratory, and a modified version (EIDD-2801) could potentially be valuable against 2019-nCoV. An antiviral compound…

The Native Antigen Company Introduces Novel Coronavirus Antigens

Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development The Native Antigen Company, one of the world’s…

Scientists from Noblis and DoD Identify Unique Genetic Sequences of Emerging Coronavirus Threat

Scientists from Noblis and the Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND),…

Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of SARS-CoV-2

Vir Biotechnology, Inc., a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious diseases, today announced that it has identified two monoclonal antibodies (mAbs)…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa